Scholars Central

Conference abstractPublished 20 Mar 2019

Up-regulation of serum mir-339-3p as a diagnostic Biomarker for non-small cell lung cancers

Authors: Keson Trakunram, Nidanut Champoochana, Pichitpon Chaniad, Sarayut Lucien Geater, Warangkana Keeratichananont, Paramee

Prince of Songkla University, Thailand

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

MicroRNAs (miRNAs), small non-coding RNA, play important role as negative regulation of gene expression. Deregulation of miRNAs has been used for predicting cancer progression in various cancers, including non-small cell lung cancer (NSCLC). Therefore, searching for potential non-invasive biomarkers is need for rapid diagnosis of lung cancer. This study aimed to evaluate whether serum miR-339-3p can be a diagnostic biomarker for NSCLC. A retrospective study was designed. Serum was collected from 151 suspected patients with lung cancer. All patients were diagnosed at Songklanagarind Hospital (Hat Yai, Thailand), a university hospital in Southern Thailand, between December 2017 and September 2018. Expression of miR-339-3p was determined by quantitative real-time PCR (qRT-PCR) technique. Receiver operating characteristic (ROC) curve and the area under the curve (AUC) were used to test the diagnostic performance. Result showed that 66 patients were NSCLC and 85 patients were non- NSCLC. The mean relative expression of serum miR-339-3p in NSCLC patients was approximately two times higher compared with that of non-NSCLC patients with P-value of 0.009. In addition, the ROC curve data indicated that this serum miR-339-3p can distinguish the NSCLC patients from the non-NSCLC patients with the AUC of 0.624 (95% CI: 0.53-0.71). The sensitivity was 73% and the specificity was 45%. In conclusion, serum miR-339-3p may serve as a circulating biomarker for diagnosis of lung cancer.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCancer Science & Therapy
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Keson Trakunram”
  • BylineArticles whose byline prints “Nidanut Champoochana”
  • BylineArticles whose byline prints “Pichitpon Chaniad”
  • BylineArticles whose byline prints “Sarayut Lucien Geater”
  • BylineArticles whose byline prints “Warangkana Keeratichananont”
  • BylineArticles whose byline prints “Paramee”